A higher adherence to a Mediterranean diet is linked to a lower risk of developing MS, particularly in nonsmokers and people ...
Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...
Signs of multiple sclerosis may surface years before diagnosis, as patients use healthcare more often for early symptoms.
A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...
Mendelian randomization revealed a significant link between higher genetically-determined BMI and increased MS severity, strengthening previous observational findings. Expanded analysis included ...
Changes in NAWM and NAGM are crucial in MS progression, challenging the traditional lesion-centric model. Subtle alterations in myelin integrity, immune cell function, and neuronal connectivity ...
When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that ...
A team of scientists from the New York Stem Cell Foundation (NYSCF) Research Institute and Case Western Reserve University has created the largest reported collection of stem cell models from multiple ...
Berger has participated in meetings (lectures, advisory boards, consultations) sponsored and compensated by pharmaceutical ...
"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...
Professional societies of neurologists, including most prominently the American Academy of Neurology (AAN) and the European Academy of Neurology (EAN) periodically release recommendations to guide ...
"One of the things that remains a puzzle for us, as it was 10 years ago, is why some people are able to have MS and not experience cognitive decline whereas others do have cognitive decline." — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results